Lee, J. S., Murphy, W. K., Shirinian, M. H., Pang, A., & Hong, W. K. (1991). Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: Potential for improved therapeutic efficacy. Cancer chemotherapy and pharmacology, 28(3), 199. https://doi.org/10.1007/BF00685509
Chicago Style (17th ed.) CitationLee, J S., W K. Murphy, M H. Shirinian, A. Pang, and W K. Hong. "Alleviation by Leucovorin of the Dose-limiting Toxicity of Edatrexate: Potential for Improved Therapeutic Efficacy." Cancer Chemotherapy and Pharmacology 28, no. 3 (1991): 199. https://doi.org/10.1007/BF00685509.
MLA (9th ed.) CitationLee, J S., et al. "Alleviation by Leucovorin of the Dose-limiting Toxicity of Edatrexate: Potential for Improved Therapeutic Efficacy." Cancer Chemotherapy and Pharmacology, vol. 28, no. 3, 1991, p. 199, https://doi.org/10.1007/BF00685509.